Apollo Hospitals Enterprise Limited reported remarkable financial results for the third quarter of fiscal year 2025, showcasing substantial growth across key performance metrics. The healthcare giant announced its earnings on February 10, 2025, indicating its commitment to accessibility and quality healthcare across India.
During the Q3 FY25 results, Apollo Hospitals highlighted a net profit of Rs 379.4 crore, reflecting a significant 49.1% increase year-on-year from Rs 254.4 crore recorded during the same period last year. Revenue from operations surged to Rs 5,527 crore, up from Rs 4,851 crore, marking a 13.9% growth, as mentioned in the company’s regulatory filing. The EBITDA also demonstrated impressive growth, rising 24.1% to reach Rs 761 crore compared to Rs 613.7 crore the previous year.
Prathap C. Reddy, Chairman of Apollo Hospitals, emphasized the importance of these results, stating, "The results reflect our growth story... quality healthcare is not a privilege but a fundamental right for all." His comments underline Apollo's pursuit to make healthcare services accessible, as the company continues to expand its footprint across India.
The board of directors at Apollo Hospitals declared an interim dividend of Rs 9 per share, which corresponds to 180% of the face value of Rs 5. The record date for this dividend payment is February 15, 2025, and eligible shareholders will receive the payment on or before February 28, 2025. This dividend declaration is indicative of the firm’s healthy financial health and commitment to returning value to its shareholders.
Apollo Hospitals is also focused on strategic expansion. The company plans to add 3,512 beds across 11 new locations over the next three to four years, set to begin fiscal year 2026. This proactive growth approach signifies the hospital's relentless effort to cater to the increasing healthcare demands of the nation.
On the digital transformation front, Apollo HealthCo, the digital healthcare and omnichannel pharmacy platform of Apollo, reported revenue growth of 15% year-on-year, totalling Rs 2,352 crore. Both offline pharmacy distribution revenues and digital platform revenues were significant contributors, recording Rs 208 crore and Rs 274 crore respectively during the third quarter.
To bolster its digital healthcare offerings, Apollo Hospitals has partnered with Microsoft, which aims to accelerate AI-driven healthcare transformation and innovations. Reddy mentioned, "Our partnership with Microsoft is accelerating AI-driven healthcare transformation, including innovation in disease progression and genomics," highlighting the integration of cutting-edge technology to improve healthcare services.
The company also collaborates with the University of Leicester to train healthcare professionals and invest in enhancing skillsets required for modern healthcare delivery. This initiative is part of Apollo's broader vision to build capabilities within India's healthcare system.
On the stock market front, shares for Apollo Hospitals garnered attention following the earnings release. Despite the company's impressive performance, its shares experienced minor fluctuations and settled down slightly at Rs 6,761.25 on the NSE.
The significant financial achievements and strategic advancements by Apollo Hospitals not only reflect the company's growth story but also reinforce its commitment to shaping the future of healthcare delivery across India. With sustained expansion efforts and the embrace of innovative technologies, we can expect Apollo Hospitals to continue setting benchmarks within the healthcare industry.
Overall, these results paint a promising picture of Apollo Hospitals Enterprise as it seeks to balance its growth with quality healthcare delivery, emphasizing the motto of treating healthcare as a fundamental right.